Skip to main content


The global gene therapy market was valued at $3,407.5 million in 2019. According to the forecast of P&S Intelligence, a market research company based in India, the market will advance at a CAGR of 31.1% between 2020 and 2030. The positive results of various clinical trials, the increasing prevalence of chronic diseases, and the soaring R&D (research and development) activities being conducted in gene therapy are the main factors fueling the advancement of the market.


Comments